ConductScience.org, home

Trial · NCT02002819

Outcomes17

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYChanges in Executive Function as Measured by the NIH EXAMINER Computer BatteryDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)score on a scaleMEAN
SECONDARYChanges in Stroop Interference NamingDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)score on a scaleMEAN
SECONDARYChanges in ADAS-cogDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)24 participants in this study did the ADAS-cog at both baseline and treatment.score on a scaleMEAN
SECONDARYClinical Dementia Rating Sum of Boxes (CDR-SOB)Difference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)score on a scaleMEAN
SECONDARYChanges in Behavior and Level of Disability - ADCS-ADLDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)score on a scaleMEAN
SECONDARYChanges in Behavior and Level of Disability - ADCS-CGICDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)score on a scaleMEAN
SECONDARYChanges in Behavior and Level of Disability - Neuropsychiatric Inventory (NPI)Difference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)score on a scaleMEAN
SECONDARYChanges in Epileptiform EventsDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)Epileptiform eventsMEAN
OTHER_PRE_SPECIFIEDStroop Interference in AD With Epileptiform ActivityDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)Specifically, this analysis is only looking at individuals who displayed epoileptiform activity.score on a scaleMEAN
OTHER_PRE_SPECIFIEDADAS-cog in AD With Epileptiform ActivityDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)Specifically, this analysis is only looking at individuals who displayed epileptiform activity.score on a scaleMEAN
OTHER_PRE_SPECIFIEDChanges in Cognitive Function as Measured by a Virtual Route Learning TestDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)correct turnsMEAN
OTHER_PRE_SPECIFIEDStandardized Assessments of Clinical Fluctuations -The Clinician Assessment of FluctuationDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)score on a scaleMEAN
OTHER_PRE_SPECIFIEDBlood Serum Prolactin LevelDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)ng/mLMEAN
OTHER_PRE_SPECIFIEDNIH EXAMINER in AD With Epileptiform ActivityDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)Specifically, this analysis is only looking at individuals who displayed epileptiform activity.score on a scaleMEAN
OTHER_PRE_SPECIFIEDStandardized Assessments of Clinical Fluctuations - One Day Fluctuation Assessment ScaleDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)score on a scaleMEAN
OTHER_PRE_SPECIFIEDMEG Power Spectrum MeasuresDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)
OTHER_PRE_SPECIFIEDMEG Functional Connectivity MeasuresDifference between weeks 0-4 (Baseline) and weeks 8-12 (Treatment)

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02002819/outcomes